A phase 3 trial shows that once-weekly semaglutide significantly improves liver histology in patients with metabolic ...

Maria Teresa Borrello does not work for, consult, own shares in or receive funding from any company or organization that would benefit from this article, and has disclosed no relevant affiliations ...

A recent US study reveals that many herbal and dietary supplements, commonly taken for health benefits, may pose liver risks. Researchers found that a significant percentage of adults consume ...

Ozempic, a diabetes drug, shows promise for liver disease. Research indicates it can reverse non-alcoholic steatohepatitis. A study reveals significant liver health improvements in patients.

International study looked at 800 patients in 37 countries Patients getting the drug saw less inflammation and fat in their livers Lead researcher says it could help treat liver disease like MASH ...

Naim Alkhouri, MD, spoke to the potential for glucagon-like peptide-1 (GLP-1) receptor agonists to transform the treatment ...

Roche is rolling out a new diagnostic test to help assess hidden liver fibrosis in patients showing signs of metabolic dysfunction-associated steatotic liver disease, or MASLD. The company said ...

For patients with chronic viral hepatitis, clinicians instinctively rely on liver enzyme measurements to estimate disease activity and assess need for liver biopsy or antiviral treatment.

It’s a mantra which I have pinned to my desk and by which I try to live every day after my life was turned upside down when I was diagnosed with cholangiocarcinoma, an aggressive type of liver ...